377085-07-9

Upstream product

• 98-88-4 benzoyl chloride 
• 377085-06-8 ((3aS,5R,6S,6aS)-5-Hydroxymethyl-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-6-yl)-methanol 
• 609-06-3 L-xylose 
• 377085-05-7 [(3aS,5R,6S,6aS)-5-(tert-Butyl-diphenyl-silanyloxymethyl)-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-6-yl]-methanol 
• 377085-04-6 tert-butyl-(2,2-dimethyl-6-methylene-tetrahydro-furo[2,3-d][1,3]dioxol-5-ylmethoxy)-diphenyl-silane 
• 131156-47-3 (3aS,3bR,7aS,8aS)-2,2,5,5-tetramethyltetrahydro-3aH-[1,3]dioxolo[4',5':4,5]furo[3,2-d][1,3]dioxane 
• 220827-74-7 (2S,3R,5R)-5-O-(tert-butyldiphenylsilyl)oxymethyl-1,2-O-isopropylidene-2,3-dioxytetrahydrofuran-4-one 
• 114861-22-2 1,2-O-isopropylidene-α-L-xylofuranose 
• 220827-73-6 5-O-tert-butyldiphenylsilyl-1,2-O-isopropylidene-α-L-xylofuranose 

Downstream Products

• 377085-09-1 C₂₇H₂₆N₂O₉ 
• 377085-08-0 C₂₄H₂₄O₉ 

Relevant academic research and scientific papers

Synthesis of novel D- and L-3′-deoxy-3′-C-Hydroxymethyl nucleoside with exocyclic methylene as potential ribonucleotide reductase inhibitor

D- and L-3′-Deoxy-3′-C-hydroxymethyl thymidine substituted with exocyclic methylene at 2′-position were synthesized, starting from D- and L-xylose as potential ribonucleotide reductase inhibitor, respectively, but they were found to be inactive against several tumor cell lines.